Lynn Nonnemaker at McDermott Will & Schulte

CMS releases 2027 policy and technical changes to Medicare Advantage and Part D proposed rule

On November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that puts forth policy and technical changes to the Medicare Advantage (MA) and Part D programs for 2027 and beyond....more

12/4/2025 / Centers for Medicare & Medicaid Services (CMS) , Comment Period , Health Insurance , Inflation Reduction Act (IRA) , Marketing , Medicare Advantage , Medicare Part D , Prescription Drugs , Proposed Rules , Regulatory Oversight , Regulatory Reform , Regulatory Requirements , Request For Information , Risk Adjustment Formula , Star Ratings

The 2027 MA and Part D proposed rule: What’s in and what’s out

Last week, right before you enjoyed your Thanksgiving feast, the Centers for Medicare & Medicaid Services (CMS) released a proposed rule that lays out policy and technical changes to the Medicare Advantage (MA) and Part D...more

12/4/2025 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Deregulation , Executive Orders , Health Insurance , Medicare Advantage , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Proposed Rules , Regulatory Oversight , Regulatory Reform , Regulatory Requirements , Request For Information , Risk Management , Star Ratings

Key issues in Medicare Advantage

The past several years have been active in the policy space for Medicare Advantage (MA) stakeholders, including 2025, which has seen two final rules released (to date), following publication in December 2024 of a proposed...more

10/17/2025 / Centers for Medicare & Medicaid Services (CMS) , Final Rules , Marketing , Medicare , Medicare Advantage , Prior Authorization , Proposed Legislation , Proposed Rules , Regulatory Oversight , Regulatory Requirements , Risk Adjustment Formula , Star Ratings , Supplemental Benefits

The government shutdown’s impact on Medicare Advantage: As clear as mud?

McDermott+ is pleased to bring you Regs & Eggs, a weekly Regulatory Affairs blog by Jeffrey Davis. October 16, 2025 – Over the last couple of weeks, stakeholders have raised many questions about how the government shutdown...more

10/16/2025 / Centers for Medicare & Medicaid Services (CMS) , Claims Processing Systems , Government Shutdown , Health Insurance , Medicare , Medicare Advantage , New Guidance , Proposed Rules , Rulemaking Process , Statutory Deadlines , Telehealth

The regulatory outlook for Medicare Advantage

We are in a busy season for regulations, as discussed in last week’s Regs & Eggs blog post. One Centers for Medicare & Medicaid Services (CMS) rule now under review at the Office of Management and Budget (OMB) will be of...more

9/4/2025 / Biden Administration , Centers for Medicare & Medicaid Services (CMS) , Final Rules , Inflation Reduction Act (IRA) , Medicare Advantage , Medicare Part D , OMB , Proposed Rules , Regulatory Oversight , Rulemaking Process , Trump Administration

CMS releases CY 2026 Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System proposed rule

On July 15, 2025, the Centers for Medicare & Medicaid Services (CMS) released the Calendar Year (CY) 2026 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems Proposed Rule [CMS-1834-P],...more

7/18/2025 / Ambulatory Surgery Centers , Centers for Medicare & Medicaid Services (CMS) , Financial Services Industry , Healthcare , Healthcare Reform , Medicare , Outpatient Prospective Payment System (OPPS) , Payment Systems , Proposed Rules , Regulatory Requirements , Reporting Requirements

Health Plans’ Commitment to Prior Authorization Improvements: What’s New Versus What’s Already Required

Health plan members of AHIP and the Blue Cross and Blue Shield Association made news earlier this week when they announced a series of steps that a broad swath of health insurers will take to improve the prior authorization...more

6/26/2025 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Health Insurance , Healthcare , Healthcare Reform , Insurance Industry , Medicare Advantage , New Regulations , Prior Authorization , Regulatory Reform , Regulatory Requirements

President Trump Issues Most Favored Nations Drug Pricing Executive Order

While much of Washington, DC’s attention this week has been focused on congressional action around budget reconciliation, including proposed changes to the Medicaid program, the White House also made news with release of a...more

5/15/2025 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Executive Orders , Food and Drug Administration (FDA) , Imports , Medicaid , Medicare , Prescription Drugs , Trump Administration

An MA Extravaganza: Overview of the Final Rule and Rate Announcement

This past week, the Trump administration put its first major stamp on the Medicare Advantage (MA) program. The Centers for Medicare & Medicaid Services (CMS) released two final regulatory documents related to MA: - The...more

4/10/2025 / Artificial Intelligence , Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Final Rules , Healthcare , Healthcare Reform , Inflation Reduction Act (IRA) , Medicare Advantage , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Regulatory Requirements , Risk Management , Rulemaking Process , Technology Sector

2026 Medicare Advantage and Part D Final Rate Notice: What to Expect

Key Takeaways - - CMS is expected to issue the 2026 final rate notice for Medicare Advantage (MA) and Part D plans by April 7, 2025. - The January 2025 advance notice proposed policies that would increase payments to MA...more

3/26/2025 / Centers for Medicare & Medicaid Services (CMS) , Final Rules , Medicare , Medicare Advantage , Medicare Part D , Prescription Drugs , Proposed Rules , Regulatory Agenda , Risk Management , Trump Administration

CY 2026 MA and Part D Final Reg: Policies Under Consideration

Last week, the contract year (CY) 2026 Medicare Advantage (MA) and Part D final reg entered the clearance process at the Office of Management and Budget (OMB). As mentioned in a previous Regs & Eggs blog post, OMB’s review is...more

3/13/2025 / Artificial Intelligence , Centers for Medicare & Medicaid Services (CMS) , Final Rules , Inflation Reduction Act (IRA) , Medicaid , Medicare , Medicare Advantage , Medicare Part D , Medicare Payment Reform , Mental Health , OMB , Pharmaceutical Industry , Prescription Drugs , Prior Authorization , Proposed Rules , Technology , Utilization Review

Value-Based Care at a Crossroads: What’s Next and How To Prepare

The Trump administration will have its own vision on value-based care, creating specific priorities for the Center for Medicare & Medicaid Innovation (CMMI), the federal government’s primary testing ground for payment and...more

2/26/2025 / Centers for Medicare & Medicaid Services (CMS) , CMMI , Department of Health and Human Services (HHS) , Health Care Providers , Health Insurance , Healthcare Reform , Medicaid , Medicare , Trump Administration , Value-Based Care , Value-Based Payments

The Future of Medicare Advantage: Q&A with McDermott+’s Lynn Nonnemaker

A few weeks ago, Regs & Eggs provided insights into Medicare Advantage (MA), the private insurance option under Medicare, and explored both short- and long-term actions that the Trump administration could take to modify MA...more

2/13/2025 / Centers for Medicare & Medicaid Services (CMS) , Health Insurance , Healthcare , Healthcare Reform , Insurance Industry , Medicare , Medicare Advantage , Medicare Part D , Proposed Rules , Regulatory Agenda , Trump Administration

Lynn Nonnemaker

McDermott Will & Schulte

Popular Topics by This Author

Latest Publications